Wang Haiyang, Huang Yuliang, Hu Qiaoqiao, Li Chenguang, Liu Hongjia, Wang Xuejuan, Li Weibo, Ma Wenjun, Pu Yichen, Du Yixiao, Wu Hao, Zhang Yibao
Laboratory Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
Laboratory Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China.
Front Oncol. 2021 Jan 25;10:543147. doi: 10.3389/fonc.2020.543147. eCollection 2020.
Frequency of conventional kV-image guidance is sometimes sacrificed to reduce concomitant risk, leaving deviations of unguided fractions unknown. MV-imaging and treatment dose can be collectively optimized on Halcyon, where fractional MVCBCT provides complete anatomic records for course-wide dose reconstruction. By retrospective dose accumulation, this work simulated the impact of imaging frequency on patient treatment dose on the platform of Halcyon.
Four hundred and sixteen MVCBCT image sets from 16 patients of various tumor sites treated with radiotherapy on Halcyon were retrospectively selected. After applying the image-guided couch shifts of the clinical records, deformable image registration was performed using Velocity software, to deform the planning CTs to the corresponding MVCBCTs, generating pseudo CTs representing the actual anatomies on the treatment day. Fractional treatment dose was reconstructed on pseudo CTs for accumulation, representing the actual patient dose (D). To simulate weekly image guidance, fractional dose was reconstructed and accumulated by incorporating 1 CBCT-guided corrections and 4 laser-guided setups of each week (D). Limited by partially imaged volumes and different organs-at-risk of various sites, only target dose-volume parameters were evaluated across all patients.
GTV_D98%, CTV_D98%, PTV_D90%, PTV_D95%, PGTV_D90%, and PGTV_D95% were evaluated, where Dx% means the minimal dose received by x% volume. Pairwise comparisons were made between plan dose and D, D and D respectively. PGTV_D of accumulated D were significantly lower than those of accumulated D by up to 32.90% of prescription dose, suggesting that weekly-guidance may result in unacceptable under dose to the target. The broad distribution of fractional differences between D and D suggested unreliable patient positioning based on aligning surface markers to laser beams, as a popular approach broadly used on conventional Linac systems. Slight target under-dose was observed on daily reconstructed results compared with planned dose, which provided quantitative data to guide clinical decisions such as the necessity of adaptive radiotherapy.
Fractional image guided radiotherapy on Halcyon provides more reliable treatment accuracy than using sacrificed imaging frequency, which also provides complete anatomic records for deformable dose reconstruction supporting more informed clinical decisions.
为降低相关风险,有时会牺牲传统千伏图像引导的频率,从而使未引导分次的偏差情况不明。在Halcyon平台上,可对兆伏成像和治疗剂量进行联合优化,其中分次MVCBCT可为全疗程剂量重建提供完整的解剖记录。通过回顾性剂量累积,本研究模拟了成像频率对Halcyon平台上患者治疗剂量的影响。
回顾性选取了在Halcyon上接受放射治疗的16例不同肿瘤部位患者的416套MVCBCT图像集。应用临床记录中的图像引导床位移后,使用Velocity软件进行可变形图像配准,将计划CT变形为相应的MVCBCT,生成代表治疗日实际解剖结构的伪CT。在伪CT上重建分次治疗剂量以进行累积,代表实际患者剂量(D)。为模拟每周图像引导,通过纳入每周1次CBCT引导校正和4次激光引导设置来重建和累积分次剂量(D)。受部分成像体积和不同部位不同危及器官的限制,仅对所有患者的靶区剂量体积参数进行评估。
评估了GTV_D98%、CTV_D98%、PTV_D90%、PTV_D95%、PGTV_D90%和PGTV_D95%,其中Dx%表示x%体积所接受的最小剂量。分别对计划剂量与D、D与D进行了两两比较。累积D的PGTV_D比累积D的PGTV_D显著低至处方剂量的32.90%,表明每周引导可能导致靶区剂量不足,无法接受。D与D之间分次差异的广泛分布表明,基于将体表标记与激光束对齐的患者定位方法不可靠,这是传统直线加速器系统广泛使用的一种常用方法。与计划剂量相比,在每日重建结果中观察到轻微的靶区剂量不足,这为指导诸如自适应放射治疗必要性等临床决策提供了定量数据。
Halcyon上的分次图像引导放射治疗比牺牲成像频率提供了更可靠的治疗精度,同时也为可变形剂量重建提供了完整的解剖记录,有助于做出更明智的临床决策。